CNTB

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Connect Biopharma Holdings Ltd

NASDAQ | CNTB

1.61

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 12, 2025)

$84.71M

Market Cap

-

P/E Ratio

-0.81

EPS

$2.86

52 Week High

$0.51

52 Week Low

HEALTHCARE

Sector

CNTB Chart

Recent Chart
Price Action

CNTB Technicals

Tags:

CNTB Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $26M
Total Revenue $26M
Cost Of Revenue $660K
Costof Goods And Services Sold $660K
Operating Income -$22M
Selling General And Administrative $19M
Research And Development $29M
Operating Expenses $48M
Investment Income Net -
Net Interest Income $4.5M
Interest Income $4.5M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $660K
Income Before Tax -$15M
Income Tax Expense $223K
Interest And Debt Expense -
Net Income From Continuing Operations -$16M
Comprehensive Income Net Of Tax -
Ebit -$22M
Ebitda -$22M
Net Income -$16M

Revenue & Profitability

Earnings Performance

CNTB Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $101M
Total Current Assets $97M
Cash And Cash Equivalents At Carrying Value $78M
Cash And Short Term Investments $78M
Inventory -
Current Net Receivables $1.1M
Total Non Current Assets $4.3M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $53K
Intangible Assets Excluding Goodwill $53K
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $15M
Other Current Assets $2.2M
Other Non Current Assets -
Total Liabilities $9.1M
Total Current Liabilities $8.5M
Current Accounts Payable $342K
Deferred Revenue -
Current Debt -
Short Term Debt $308K
Total Non Current Liabilities $656K
Capital Lease Obligations $178K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $178K
Other Current Liabilities $7.6M
Other Non Current Liabilities $632K
Total Shareholder Equity $92M
Treasury Stock -
Retained Earnings -$345M
Common Stock $10K
Common Stock Shares Outstanding $55M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$24M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $660K
Capital Expenditures $750K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$3.5M
Cashflow From Financing $227K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$16M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $26M
Total Revenue $26M
Cost Of Revenue $660K
Costof Goods And Services Sold $660K
Operating Income -$22M
Selling General And Administrative $19M
Research And Development $29M
Operating Expenses $48M
Investment Income Net -
Net Interest Income $4.5M
Interest Income $4.5M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $660K
Income Before Tax -$15M
Income Tax Expense $223K
Interest And Debt Expense -
Net Income From Continuing Operations -$16M
Comprehensive Income Net Of Tax -
Ebit -$22M
Ebitda -$22M
Net Income -$16M

CNTB News

CNTB Profile

Connect Biopharma Holdings Ltd Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical firm headquartered in Taicang, China, specializing in the discovery and development of innovative immune modulators targeted at severe autoimmune diseases and inflammatory conditions. With a robust pipeline of product candidates, the company is dedicated to addressing significant unmet medical needs, highlighting its potential to deliver breakthrough therapies that improve patient outcomes. By harnessing advanced scientific research, Connect Biopharma is strategically positioned to make substantial contributions to the global biopharmaceutical market, targeting sustainable growth and long-term impact in the healthcare sector.

LPTX
+368.57%
$2.05
AMZE
-10.20%
$0.48
PLUG
+7.90%
$2.73
NVDA
+0.33%
$193.80
YDKG
-7.57%
$0.02
AMD
+8.99%
$258.89
SOFI
+4.07%
$32.21
PFE
+1.43%
$25.87
ASST
-5.14%
$1.29
ACHR
-3.52%
$8.62
BYND
-8.95%
$1.22
VHAI
0.00%
$0.00
BITF
-5.93%
$3.17
CLSK
-6.55%
$14.04
ONDS
-5.00%
$5.51
SLRX
+17.34%
$1.15
RIVN
-2.77%
$17.52
AXDX
-61.36%
$0.03
WTO
-15.20%
$0.03
F
+1.09%
$13.44
DNN
-0.19%
$2.58
TSLA
-2.05%
$430.60
CMCT
+88.22%
$9.43
PLTR
-3.55%
$184.17
TWOH
+10.41%
$0.00
INTC
-1.48%
$37.88
ETHD
+1.58%
$4.50
ADAP
-15.14%
$0.05
SNAP
+3.71%
$9.08
NOK
+1.88%
$7.03
RGTI
-9.87%
$28.30
QH
+48.13%
$1.23
WULF
+2.18%
$12.64
BTE
+13.67%
$3.03
ONON
+18.02%
$41.52
AAPL
-0.64%
$273.47
GRAB
-1.53%
$5.79
AAL
+3.61%
$13.46
NIO
-2.86%
$6.44
T
+1.92%
$25.66
CMND
-32.32%
$0.31
BURU
+9.42%
$0.27
BBD
-1.07%
$3.68
ASBP
-7.65%
$0.10
BAC
+0.89%
$54.11
BTG
+2.06%
$4.19
MARA
-1.50%
$14.41
RMBL
+60.50%
$3.21
CRWV
-3.34%
$85.43
QBTS
-8.93%
$26.40
ADD
-25.47%
$0.05
CRCL
-12.57%
$85.94
HPE
+2.55%
$23.47
CSCO
+3.25%
$74.04
NBIS
-7.68%
$94.36
CIFR
-4.98%
$18.67
RUBI
-13.91%
$0.19
KVUE
-0.35%
$16.66
CLF
+8.08%
$11.02
SRM
+53.27%
$10.30
DVLT
+13.19%
$1.63
TLRY
-4.65%
$1.23
EOSE
-6.74%
$17.27
RIG
-2.48%
$4.12
BKYI
+11.31%
$0.91
RKLB
-1.27%
$51.24
QS
-7.46%
$14.72
GPUS
-4.00%
$0.33
VCIG
-26.55%
$1.30
NGD
+3.76%
$7.57
CMG
+5.11%
$31.33
SOUN
-6.73%
$13.44
AMZN
-1.96%
$244.20
BTBT
-3.72%
$2.84
ITUB
-2.36%
$7.64
LYFT
+1.93%
$24.18
WLGS
-5.57%
$0.04
IREN
-2.92%
$55.70
CHR
-4.55%
$0.04
NVO
+6.98%
$49.15
IONZ
+13.52%
$4.70
ABEV
-0.19%
$2.52
PBR
-3.71%
$12.97
XPEV
-2.83%
$27.27
PSNY
-15.36%
$0.67
SMCI
-2.34%
$37.91
JOBY
-1.00%
$16.18
META
-2.88%
$609.01
LUMN
-7.62%
$8.54
VSA
-77.92%
$0.28
AFMD
-34.94%
$0.18
AGNC
-1.06%
$10.20
ORCL
-3.87%
$227.01
RXRX
-1.27%
$4.65
KEY
-1.32%
$17.84
PLTZ
+7.22%
$6.23
VALE
+0.32%
$12.34
QUBT
-6.57%
$11.15
APLD
-9.12%
$28.57
STLA
+3.86%
$10.76
LPTX
+368.57%
$2.05
AMZE
-10.20%
$0.48
PLUG
+7.90%
$2.73
NVDA
+0.33%
$193.80
YDKG
-7.57%
$0.02
AMD
+8.99%
$258.89
SOFI
+4.07%
$32.21
PFE
+1.43%
$25.87
ASST
-5.14%
$1.29
ACHR
-3.52%
$8.62
BYND
-8.95%
$1.22
VHAI
0.00%
$0.00
BITF
-5.93%
$3.17
CLSK
-6.55%
$14.04
ONDS
-5.00%
$5.51
SLRX
+17.34%
$1.15
RIVN
-2.77%
$17.52
AXDX
-61.36%
$0.03
WTO
-15.20%
$0.03
F
+1.09%
$13.44
DNN
-0.19%
$2.58
TSLA
-2.05%
$430.60
CMCT
+88.22%
$9.43
PLTR
-3.55%
$184.17
TWOH
+10.41%
$0.00
INTC
-1.48%
$37.88
ETHD
+1.58%
$4.50
ADAP
-15.14%
$0.05
SNAP
+3.71%
$9.08
NOK
+1.88%
$7.03
RGTI
-9.87%
$28.30
QH
+48.13%
$1.23
WULF
+2.18%
$12.64
BTE
+13.67%
$3.03
ONON
+18.02%
$41.52
AAPL
-0.64%
$273.47
GRAB
-1.53%
$5.79
AAL
+3.61%
$13.46
NIO
-2.86%
$6.44
T
+1.92%
$25.66
CMND
-32.32%
$0.31
BURU
+9.42%
$0.27
BBD
-1.07%
$3.68
ASBP
-7.65%
$0.10
BAC
+0.89%
$54.11
BTG
+2.06%
$4.19
MARA
-1.50%
$14.41
RMBL
+60.50%
$3.21
CRWV
-3.34%
$85.43
QBTS
-8.93%
$26.40
ADD
-25.47%
$0.05
CRCL
-12.57%
$85.94
HPE
+2.55%
$23.47
CSCO
+3.25%
$74.04
NBIS
-7.68%
$94.36
CIFR
-4.98%
$18.67
RUBI
-13.91%
$0.19
KVUE
-0.35%
$16.66
CLF
+8.08%
$11.02
SRM
+53.27%
$10.30
DVLT
+13.19%
$1.63
TLRY
-4.65%
$1.23
EOSE
-6.74%
$17.27
RIG
-2.48%
$4.12
BKYI
+11.31%
$0.91
RKLB
-1.27%
$51.24
QS
-7.46%
$14.72
GPUS
-4.00%
$0.33
VCIG
-26.55%
$1.30
NGD
+3.76%
$7.57
CMG
+5.11%
$31.33
SOUN
-6.73%
$13.44
AMZN
-1.96%
$244.20
BTBT
-3.72%
$2.84
ITUB
-2.36%
$7.64
LYFT
+1.93%
$24.18
WLGS
-5.57%
$0.04
IREN
-2.92%
$55.70
CHR
-4.55%
$0.04
NVO
+6.98%
$49.15
IONZ
+13.52%
$4.70
ABEV
-0.19%
$2.52
PBR
-3.71%
$12.97
XPEV
-2.83%
$27.27
PSNY
-15.36%
$0.67
SMCI
-2.34%
$37.91
JOBY
-1.00%
$16.18
META
-2.88%
$609.01
LUMN
-7.62%
$8.54
VSA
-77.92%
$0.28
AFMD
-34.94%
$0.18
AGNC
-1.06%
$10.20
ORCL
-3.87%
$227.01
RXRX
-1.27%
$4.65
KEY
-1.32%
$17.84
PLTZ
+7.22%
$6.23
VALE
+0.32%
$12.34
QUBT
-6.57%
$11.15
APLD
-9.12%
$28.57
STLA
+3.86%
$10.76
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.